These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 10855535)
1. Peptide mapping and characterisation of glycation patterns of the glima 38 antigen recognised by autoantibodies in Type I diabetic patients. Roll U; Turck CW; Gitelman SE; Rosenthal SM; Nolte MS; Masharani U; Ziegler AG; Baekkeskov S Diabetologia; 2000 May; 43(5):598-608. PubMed ID: 10855535 [TBL] [Abstract][Full Text] [Related]
2. IA-2 (islet cell antigen 512) is the primary target of humoral autoimmunity against type 1 diabetes-associated tyrosine phosphatase autoantigens. Bonifacio E; Lampasona V; Bingley PJ J Immunol; 1998 Sep; 161(5):2648-54. PubMed ID: 9725268 [TBL] [Abstract][Full Text] [Related]
3. Relationship of the 37,000- and 40,000-M(r) tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512). Payton MA; Hawkes CJ; Christie MR J Clin Invest; 1995 Sep; 96(3):1506-11. PubMed ID: 7657822 [TBL] [Abstract][Full Text] [Related]
4. ICA512(IA-2) epitope specific assays distinguish transient from diabetes associated autoantibodies. Miao D; Yu L; Tiberti C; Cuthbertson DD; Rewers M; di Mario U; Eisenbarth GS; Dotta F J Autoimmun; 2002 Mar; 18(2):191-6. PubMed ID: 11908951 [TBL] [Abstract][Full Text] [Related]
5. Autoantibodies to ICA12 (SOX-13) are not specific for Type I diabetes. Steinbrenner H; Lohmann T; Ostendorf B; Scherbaum WA; Seissler J Diabetologia; 2000 Nov; 43(11):1381-4. PubMed ID: 11126406 [TBL] [Abstract][Full Text] [Related]
6. Early development and spreading of autoantibodies to epitopes of IA-2 and their association with progression to type 1 diabetes. Naserke HE; Ziegler AG; Lampasona V; Bonifacio E J Immunol; 1998 Dec; 161(12):6963-9. PubMed ID: 9862731 [TBL] [Abstract][Full Text] [Related]
7. Autoantibodies in insulin-dependent diabetes recognize distinct cytoplasmic domains of the protein tyrosine phosphatase-like IA-2 autoantigen. Lampasona V; Bearzatto M; Genovese S; Bosi E; Ferrari M; Bonifacio E J Immunol; 1996 Sep; 157(6):2707-11. PubMed ID: 8805677 [TBL] [Abstract][Full Text] [Related]
8. Identification of protein tyrosine phosphatase-like IA2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40K autoantigen and a target of islet-cell antibodies. Bonifacio E; Lampasona V; Genovese S; Ferrari M; Bosi E J Immunol; 1995 Dec; 155(11):5419-26. PubMed ID: 7594559 [TBL] [Abstract][Full Text] [Related]
9. Enterovirus infection may induce humoral immune response reacting with islet cell autoantigens in humans. Härkönen T; Paananen A; Lankinen H; Hovi T; Vaarala O; Roivainen M J Med Virol; 2003 Mar; 69(3):426-40. PubMed ID: 12526055 [TBL] [Abstract][Full Text] [Related]
10. Autoimmunity to glutamic acid decarboxylase in the neurodegenerative disorder Batten disease. Ramirez-Montealegre D; Chattopadhyay S; Curran TM; Wasserfall C; Pritchard L; Schatz D; Petitto J; Hopkins D; She JX; Rothberg PG; Atkinson M; Pearce DA Neurology; 2005 Feb; 64(4):743-5. PubMed ID: 15728308 [TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of glima 38, a glycosylated islet cell membrane antigen, which together with GAD65 and IA2 marks the early phases of autoimmune response in type 1 diabetes. Aanstoot HJ; Kang SM; Kim J; Lindsay LA; Roll U; Knip M; Atkinson M; Mose-Larsen P; Fey S; Ludvigsson J; Landin L; Bruining J; Maclaren N; Akerblom HK; Baekkeskov S J Clin Invest; 1996 Jun; 97(12):2772-83. PubMed ID: 8675688 [TBL] [Abstract][Full Text] [Related]
13. Autoantibodies to IA-2 and IA-2 beta in insulin-dependent diabetes mellitus recognize conformational epitopes: location of the 37- and 40-kDa fragments determined. Xie H; Zhang B; Matsumoto Y; Li Q; Notkins AL; Lan MS J Immunol; 1997 Oct; 159(7):3662-7. PubMed ID: 9317167 [TBL] [Abstract][Full Text] [Related]
14. Autoantibodies to multiple islet autoantigens in patients with abrupt onset type 1 diabetes and diabetes diagnosed with urinary glucose screening. Sera Y; Kawasaki E; Abiru N; Ozaki M; Abe T; Takino H; Kondo H; Yamasaki H; Yamaguchi Y; Akazawa S; Nagataki S; Uchigata Y; Matsuura N; Eguchi K J Autoimmun; 1999 Sep; 13(2):257-65. PubMed ID: 10479394 [TBL] [Abstract][Full Text] [Related]
15. Value of ICA512 antibodies for prediction and diagnosis of type 1 diabetes. Mayrhofer M; Rabin DU; Messenger L; Standl E; Ziegler AG Exp Clin Endocrinol Diabetes; 1996; 104(3):228-34. PubMed ID: 8817240 [TBL] [Abstract][Full Text] [Related]
16. Autoantigens IA-2 and GAD in Type I (insulin-dependent) diabetes. Leslie RD; Atkinson MA; Notkins AL Diabetologia; 1999 Jan; 42(1):3-14. PubMed ID: 10027571 [No Abstract] [Full Text] [Related]
17. Autoantibodies associated with Type I diabetes mellitus persist after diagnosis in children. Savola K; Sabbah E; Kulmala P; Vähäsalo P; Ilonen J; Knip M Diabetologia; 1998 Nov; 41(11):1293-7. PubMed ID: 9833935 [TBL] [Abstract][Full Text] [Related]
18. MHC class I chain-related gene-A is associated with IA2 and IAA but not GAD in Swedish type 1 diabetes mellitus. Gupta M; Graham J; McNeeny B; Zarghami M; Landin-Olsson M; Hagopian WA; Palmer J; Lernmark A; Sanjeevi CB Ann N Y Acad Sci; 2006 Oct; 1079():229-39. PubMed ID: 17130560 [TBL] [Abstract][Full Text] [Related]
19. High frequency of diabetes-specific autoantibodies in parents of children with type 1 diabetes. DENIS study group. Seissler J; Atik Y; Klinghammer A; Scherbaum WA Horm Metab Res; 1999 Dec; 31(12):657-61. PubMed ID: 10668918 [TBL] [Abstract][Full Text] [Related]
20. Antibodies directed against the ectodomain of ICA512: is there any evidence in patients with diabetes mellitus? Schiel R Diabetologia; 1998 Dec; 41(12):64-5. PubMed ID: 9867225 [No Abstract] [Full Text] [Related] [Next] [New Search]